NFKB1 and neoplasm: In the same year, Peng et al. (35) and other scholars studied how chemotherapy promotes the expression of PD-L1 through the NF-κB pathway, thereby creating an immunosuppressive tumor microenvironment and its impact on the effectiveness of immunotherapy.